|
Shengmai powders for patients with myocardial infarction:a systematic review |
Hits 1587 Download times 1335 Received:August 05, 2017 |
View Full Text View/Add Comment Download reader |
DOI
10.11656/j.issn.1673-9043.2017.06.10 |
Key Words
Shengmai powers;myocardial infarction;randomized controlled trial;systematic review |
Author Name | Affiliation | E-mail | SHI Xiao-ting | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | LI Bin | The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | xxlibin2006@163.com | ZHAO Ting-kai | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | MU Biao | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | CAO Ru-mei | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | LI Xue-song | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | REN Yu-xiu | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | LI Jie | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | CHEN Hui | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | ZHANG Jin | Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | |
|
Abstract
|
[Objective] To evaluate the clinical therapeutic effect of western medicine plus Shengmai powers versus simple western medicine in myocardial infarction (MI) patients.[Methods] We systematically searched the CNKI, CBM, VIP, Wanfang, PubMed, Cochrane Library, Web of science and other related periodicals to identify randomized controlled trials(RCTs). The quality of studies was evaluated according to methods of the Cochrane Collaboration, the data were extracted; and meta-analyses were performed with RevMan5.3.0 soft ware.[Results] Eleven trials involving 766 patients were included. The results of meta-analyses showed that compared with the simple western medicine treatment, the combination of western medicine and Shengmai powers therapy significantly improved the symptoms, clinical comprehensive effect[OR=2.82,95% CI(1.57,5.50),P=0.000 5], reduce the incidence of cardiovascular events after myocardial infarction[OR=0.29,95% CI(0.15,0.54),P=0.000 1], reduce the plasma endothelin level[MD=-16.69,95% CI(-24.79,-8.60),P<0.000 1].[Conclusion] The therapeutic effect of combining western medicine with Shengmai powers therapy on myocardial infarction patients is better than that of simple western medicine treatment. |
|
|
|
|
|